Egg Phospholipids
Products in Health Canada’s databases that list Egg Phospholipids as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 7
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 10
- Products in all
- 7
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| 10% TRAVAMULSION LIQ IV (1.2 G) | 02016028 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | |
| 20% TRAVAMULSION LIQ IV (1.2 G) | 02016036 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | |
| LIPOSYN II 10% (0.9 %) | 00720976 | Cancelled Post Market | Hospira Healthcare Corporation | |
| LIPOSYN II 20% (1.2 %) | 00720968 | Cancelled Post Market | Hospira Healthcare Corporation | |
| LIPOSYN II INJ 10% (700 MG) | 00818712 | Cancelled Post Market | Hospira Healthcare Corporation | |
| LIPOSYN III 10% (12 MG) | 02366800 | Cancelled Post Market | Hospira Healthcare Corporation | |
| LIPOSYN III 20% (12 MG) | 02366819 | Cancelled Post Market | Hospira Healthcare Corporation |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- INTRALIPID 10%; INTRALIPID 20%; INTRALIPID 30%April 24, 2013 · NOC 14315
- LIPOSYN III 10%; LIPOSYN III 20%April 15, 2011 · NOC 12271
- LIPOSYN IIJanuary 16, 2009 · NOC 10000
- LIPOSYN II INJECTIONJanuary 19, 2005 · NOC 6206
- LIPOSYN IIApril 30, 2004 · NOC 1660
- INTRALIPID 10%; INTRALIPID 20%; INTRALIPID 30%May 18, 1999 · NOC 2052
- INTRALIPIDNovember 17, 1997 · NOC 4090
- LIPOSYN IIMay 6, 1997 · NOC 4053
- INTRALIPIDMarch 14, 1996 · NOC 4675
- INTRALIPIDJanuary 14, 1994 · NOC 5537